Early treatment with aminoguanidine on level of plasma and renal AngⅡ in diabetic rats
- VernacularTitle:早期应用氨基胍对糖尿病大鼠循环及肾脏血管紧张素Ⅱ水平的影响
- Author:
Shuai LIU
;
Jie SHEN
;
Jielong TANG
;
Yanfei FAN
;
Cuihua XIE
- Publication Type:Journal Article
- Keywords:
Diabetic nephropathise;
Angiotensin Ⅱ;
Albuminuria;
Aminoguanidine
- From:
Chinese Journal of Pathophysiology
2010;26(2):262-265
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To investigate the effect of aminoguanidine (AG) on plasma and renal levels of angiogenesis Ⅱ (AngⅡ), and to identify the relationship of AGEs with AngⅡ in STZ-induced diabetic rats. METHODS: Wistar rats were randomly assigned to three groups. Diabetes was induced, rats were then received AG in treatment group. At the end of 12th week, urine albumin excretion rate (UAER) and calculate creatinine clearance (Ccr) were detected. Periodic acid-Schiff reagent was used to evaluate renal pathology. Plasma and renal AngⅡ were analyzed by radioimmunoassay and immunohistochemistry, respectively. RESULTS: AG treatment significantly prevented the increase in UAER (P<0.01), renal pathology (P<0.01), and level of renal AngⅡ (P<0.01). However, plasma concentration of AngⅡ was higher than that in diabetic rats without AG treatment (P<0.01). CONCLUSION: AG down-regulates renal Ang Ⅱ level, probably by reducing the formation of AGEs, which may be one of the renoprotective factors in diabetic nephropathy. More proofs are needed to identify the result that plasma AngⅡ concentration increases in DMA group.
